Dear Chair Khan:
"On behalf of the Endocrine Society, thank you for the opportunity to provide comments on the proposed Non-Compete Clause Rule. Founded in 1916, the Endocrine Society represents approximately 18,000 physicians and scientists engaged in the treatment and research of endocrine disorders, such as diabetes, hypertension, infertility, obesity, osteoporosis, endocrine tumors and cancers (i.e., thyroid, adrenal, ovarian, pituitary), and thyroid disease. The Endocrine Society represents many physicians who have been required to sign non-compete clauses and we appreciate the Federal Trade Commission (FTC) taking steps to clarify issues and prevent unfair competition related to non-compete clauses at the federal level."
